2010 INTERPHEX Series
![]() |
Peter LathamCo-Founder and President, BioPharm Services, Inc.
|
|
![]() |
William WhitfordSenior Manager for Cell Culture and BioProcessing with Thermo Fisher Scientific
Bill looks at current discussions on risk-based PD: Where are we now?
|
|
![]() |
James BlackwellSenior Consultant, Bioprocess Technology Consultants
James discusses CMC/Regulatory issues and downstream challenges.
|
|
![]() |
George KochChief Scientific Officer and Senior Director with Diosynth
George offers a CMO's viewpoint on implementing new process technologies.
|








